SYNB1020

DRUG2 trials

Sponsors

Synlogic

Conditions

CirrhosisHealthy VolunteerUrea Cycle Disorder

Phase 1

Safety and Tolerability of SYNB1020-CP-001

CompletedNCT03179878

SynlogicHealthy Volunteer, Urea Cycle Disorder

Start: 2017-06-16End: 2018-04-11Updated: 2021-05-12

Safety, Tolerability and Pharmacodynamics of SYNB1020

TerminatedNCT03447730

SynlogicCirrhosis

Start: 2018-03-19End: 2019-07-19Updated: 2021-05-13